Company Filing History:
Years Active: 2021-2023
Title: Innovator Spotlight: Linn Schneider
Introduction
Linn Schneider, an inventive mind based in Düsseldorf, Germany, has made significant strides in her field through her innovative work at Bayer Pharma Aktiengesellschaft. With two patents to her name, Schneider exemplifies the spirit of innovation that drives advancements in the pharmaceutical industry.
Latest Patents
Linn Schneider’s latest patents reflect her commitment to enhancing measurement techniques and liquid dispensing methods. Her first patent is for a **Metering Device**, which features a housing containing a pressure chamber and a multitude of conduits for liquid delivery. This design allows for precise dispensing, enhancing the efficiency of liquid management in various applications.
Her second patent is a **Method and System for Taking Measurements in a High-Throughput Screening with High Time Resolution**. This innovative system involves a microtiter plate that facilitates rapid kinetic fluorescence measurements. The method utilizes a dispensing system that adds liquid into multiple assay wells simultaneously while an illumination system provides uniform light for accurate detection. This breakthrough technology allows for electromagnetic radiation detection within milliseconds, significantly accelerating the screening process in pharmaceutical research.
Career Highlights
At Bayer Pharma Aktiengesellschaft, Linn Schneider has made notable contributions to the field of pharmaceutical innovations. Her commitment to developing efficient systems for drug screening and delivery showcases her ability to identify and solve complex challenges within the industry.
Collaborations
Linn often collaborates with talented individuals such as Andreas Schade and Mike Küster, enriching her work through shared ideas and expertise. These collaborations play a crucial role in driving forward revolutionary innovations in their respective projects at Bayer.
Conclusion
Linn Schneider's impressive portfolio of patents and her collaborative spirit underline her significant role as an inventor in the pharmaceutical domain. Her work continues to pave the way for advancements that enhance both drug development processes and research methodologies, showcasing her impact on the industry.